Search results for “Epidermal Growth Factor Receptor Antibody” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 112 patents, we discovered top 24 key players by total patent application. Symphogen A/S, Halozyme, Inc., ImClone LLC are dominant in this area. They take 54.46% of the total patent filing.
Hovedstaden, Denmark
Patent: 25
California, United States
Patent: 20
New York, United States
Patent: 16
France
Patent: 10
Shanghai Shi, China
Patent: 5
Shanghai Shi, China
Patent: 5
Basel-Stadt, Switzerland
Patent: 3
Cuba
Patent: 3
Hessen, Germany
Patent: 3
Beijing Shi, China
Patent: 3
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 2 patents applied in the last 5 years. We discover 1 most active companies in this area.
Heilongjiang Sheng, China
Patent: 2
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 2 patents in last 5 years, we discover 1 new entrants.
Heilongjiang Sheng, China
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 11 patents, we discovered top 3 universities and scientific research institutions by total patent application.
Heilongjiang Sheng, China
Patent: 2
Georgia, United States
Patent: 1
Jilin Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: